OLEMA PHARMACEUTICALS

Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program

09 Jun 2022 07:35:00 By Nasdaq GlobeNewswire

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies

09 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Jun 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Jefferies Healthcare Conference

24 May 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update

09 May 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 May 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

04 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

08 Mar 2022 16:35:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

28 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Cowen 42nd Annual Health Care Conference

22 Feb 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Feb 2022 17:00:00 By Nasdaq GlobeNewswire

Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

31 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer

30 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media

29 Nov 2021 16:27:08 By Nasdaq GlobeNewswire

Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium

22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update

10 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Two Upcoming Investor Conferences

09 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

30 Sep 2021 17:00:00 By Nasdaq GlobeNewswire